This notification amends the CGST Rate Schedule u/s 9(1) of the Central Goods and Services Tax Act,...

This notification amends the CGST Rate Schedule u/s 9(1) of the Central Goods and Services Tax Act, 2017. It inserts three new items (Trastuzumab Deruxtecan, Osimertinib, Durvalumab) under the 2.5% tax rate schedule. It adds extruded or expanded savoury/salted products under the 6% tax rate. It modifies the 9% rate schedule by substituting the entry for un-fried/un-cooked snack pellets and seats other than aircraft/motor vehicle seats. It inserts a new entry for seats of motor vehicles under the 14% tax rate. The notification comes into force on 10th October 2024. .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X